NO951740L - Preparater av eikebarkekstrakt, beslektede syntetiske preparater og fremgangsmåte for anvendelse av disse - Google Patents

Preparater av eikebarkekstrakt, beslektede syntetiske preparater og fremgangsmåte for anvendelse av disse

Info

Publication number
NO951740L
NO951740L NO951740A NO951740A NO951740L NO 951740 L NO951740 L NO 951740L NO 951740 A NO951740 A NO 951740A NO 951740 A NO951740 A NO 951740A NO 951740 L NO951740 L NO 951740L
Authority
NO
Norway
Prior art keywords
oak bark
preparations
bark extract
ions
methods
Prior art date
Application number
NO951740A
Other languages
English (en)
Other versions
NO951740D0 (no
Inventor
David N S Hon
Thomas R Stanley
Original Assignee
H E Stanley Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H E Stanley Pharmaceuticals filed Critical H E Stanley Pharmaceuticals
Publication of NO951740D0 publication Critical patent/NO951740D0/no
Publication of NO951740L publication Critical patent/NO951740L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Road Paving Structures (AREA)
  • Laminated Bodies (AREA)

Abstract

Høyere konsentrasjoner av eikebarkaske-ekstrakt, dvs. høyere enn 20 vekt-*, er nyttig for behandling av hudkreft. Lavere konsentrasjoner av eikebarkekstrakt har l tillegg terapeutiske egenskaper som hittil Ikke har vært erkjent. For eksempel er preparater Inne- holdende 40-80 % eikebarkekstrakt nyttige ved be- handling av akutte canserøse hudsår. I tillegg tilvelebrlnger syntetiske blandinger inneholdende kaliumioner, slnkloner, kalsiumloner mange av de samme fordelaktige egenskapene som eikebarkekstrakt. Innbefatnlng av rubidlumioner og svovel er også fordelaktig for visse anvendelser.
NO951740A 1992-11-06 1995-05-04 Preparater av eikebarkekstrakt, beslektede syntetiske preparater og fremgangsmåte for anvendelse av disse NO951740L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97307192A 1992-11-06 1992-11-06
PCT/US1993/010670 WO1994011010A2 (en) 1992-11-06 1993-11-04 Compositions of oak bark extract, related synthetic compositions, and method of using same

Publications (2)

Publication Number Publication Date
NO951740D0 NO951740D0 (no) 1995-05-04
NO951740L true NO951740L (no) 1995-06-19

Family

ID=25520460

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951740A NO951740L (no) 1992-11-06 1995-05-04 Preparater av eikebarkekstrakt, beslektede syntetiske preparater og fremgangsmåte for anvendelse av disse

Country Status (21)

Country Link
US (1) US6149947A (no)
EP (1) EP0668769B1 (no)
JP (1) JP3640215B2 (no)
AT (1) ATE191850T1 (no)
AU (1) AU700019B2 (no)
BR (1) BR9307401A (no)
CA (1) CA2148795C (no)
CY (1) CY2231B1 (no)
CZ (1) CZ117395A3 (no)
DE (1) DE69328438T2 (no)
DK (1) DK0668769T3 (no)
ES (1) ES2147780T3 (no)
HU (1) HUT73791A (no)
MX (1) MX9306960A (no)
NO (1) NO951740L (no)
NZ (1) NZ258019A (no)
OA (1) OA10153A (no)
PL (1) PL308770A1 (no)
PT (1) PT668769E (no)
WO (1) WO1994011010A2 (no)
ZA (1) ZA938274B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7014870B1 (en) * 1992-11-06 2006-03-21 Greystone Medical Group, Inc. Compositions of oak bark extract related synthetic compositions and method of using same
AUPN104895A0 (en) * 1995-02-10 1995-03-09 Lai, John Methods of and preparations for the treatment of ailments and disorders
US20040037898A1 (en) * 1997-10-08 2004-02-26 Hon David N.S Compositions of oak bark extract, related synthetic compositions and method of using same
RU2125460C1 (ru) * 1997-11-17 1999-01-27 Закрытое акционерное общество научно-производственная фирма "Новь" Биостимулирующее средство
US20050033251A1 (en) * 1998-12-08 2005-02-10 Quick-Med Technologies, Inc. Controlled release of biologically active substances from select substrates
CA2468390A1 (en) * 2001-11-29 2003-06-05 Greystone Medical Group, Inc. Treatment of wounds and compositions employed
US20040170703A1 (en) * 2001-11-29 2004-09-02 Greystone Medical Group, Inc. Reduction of reactive oxygen species in chronic wound management
US6667026B1 (en) 2002-03-15 2003-12-23 Pocono Falls, Inc. Allergic contact dermatitis treatment and composition therefor
EP1507542A4 (en) * 2002-05-24 2008-01-23 Greystone Medical Group Inc ANTICANCER PREPARATION
CN1744819A (zh) * 2002-12-23 2006-03-08 格雷斯通医疗集团有限公司 慢性伤口护理中的活性氧物质的还原
WO2005000328A1 (en) * 2003-06-24 2005-01-06 Zanti Gianfranco Compositions based on plant ash for the treatment of skin diseases
US20060105017A1 (en) * 2004-06-22 2006-05-18 Greystone Medical Group, Inc. Methods for treatment of wounds using time release compositions
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
WO2007089267A1 (en) 2006-02-03 2007-08-09 Jr Chem, Llc Anti-aging treatment using copper and zinc compositions
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
EP2173363B1 (en) 2007-03-15 2016-12-07 Om Kataria Uterine stimulant sticks
EP2211868B1 (en) 2007-10-15 2017-08-02 7 Oaks Pharmaceutical Corporation Silicate containing compositions for the treatment of melanoma
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
CA2750636C (en) 2009-01-23 2017-07-25 Jr Chem, Llc Rosacea treatments and kits for performing them
US20110200655A1 (en) * 2010-02-16 2011-08-18 Michael Darryl Black Systems and methods that kill infectious agents (bacteria) without the use of a systemic anti-biotic
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
US8828449B2 (en) 2012-01-26 2014-09-09 Libby Robinson Wound dressing composition and method of use
US9351995B1 (en) 2011-04-29 2016-05-31 Red Oax Holdings, LLC Compositions and methods of enhancing wound healing
US20140249462A1 (en) 2011-07-20 2014-09-04 3M Innovatative Properties Company Dressing with ion-carrying composition
US20140194803A1 (en) * 2011-07-28 2014-07-10 Regents Of The University Of Minnestoa Wound-healing compositions and method of use
EP2744527B1 (en) 2011-08-17 2019-04-17 3M Innovative Properties Company Wound dressing with hydrophilic monomer-grafted fibers
GB201402672D0 (en) 2014-02-14 2014-04-02 Medical Res Council Materials and methods relating to stabilised polymeric silicate compositions
WO2016123539A1 (en) 2015-01-29 2016-08-04 Wardell Mark R Wound healing compositions involving medicinal honey, mineral ions, and methylglyoxal, and methods of use
PL3921422T3 (pl) * 2019-03-04 2024-04-02 Aurealis Therapeutics AG Indukowalny chlorkiem prokariotyczny układ ekspresji
IT201900018047A1 (it) * 2019-10-07 2021-04-07 Nello Vallicella Procedimento per la preparazione di una composizione topica liquida.
WO2024196897A1 (en) * 2023-03-22 2024-09-26 Courtland Imel Novel methods for increasing healing speed of human and animal wounds

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US37901A (en) * 1863-03-17 Improved liniment
US256847A (en) * 1882-04-25 Salve
US202246A (en) * 1878-04-09 Improvement in medical compounds
US55911A (en) * 1866-06-26 Improved medical compound
DE819127C (de) * 1949-09-28 1951-10-29 Heinz Dr Bauer Verfahren zur Herstellung eines Heilbades gegen Hautekzeme
DE812341C (de) * 1950-03-07 1951-08-27 Penicillin Ges Dauelsberg & Co Verfahren zur Herstellung eines Hautbehandlungsmittels
DE833840C (de) * 1950-06-01 1952-03-13 Dr Heinz Bauer Verfahren zur Herstellung einer Salbe gegen Hautekzeme
US3928584A (en) * 1969-06-30 1975-12-23 Us Health Education & Welfare Extracts from active tree saps for treating P388 mouse leukemia
US4059695A (en) * 1974-02-14 1977-11-22 Kanari Hirosaki Method for manufacturing a tonic composition for man and other animals
JPS60164467A (ja) * 1984-02-07 1985-08-27 Rooman Kogyo:Kk 飲料
ATE69954T1 (de) * 1985-10-08 1991-12-15 Psori Med Ag Salzmischung zur behandlung der schuppenflechte (psoriasis) und anderer hautkrankheiten.
US4847083A (en) * 1986-04-02 1989-07-11 Dermasciences, Inc. Two-step procedure for indolent wound healing and aqueous medium and topical ointment used in connection therewith
BE1000950A3 (fr) * 1987-10-05 1989-05-23 Claude Patricia Produit de beaute saliaris au sel de la mer morte et a l'argile verte de haute provence.
AT393221B (de) * 1988-02-03 1991-09-10 Leopold Pharma Gmbh Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken
US5080900A (en) * 1990-04-17 1992-01-14 Stanley R Thomas Treatment of skin ulcers with an aqueous extract of oak bark ash

Also Published As

Publication number Publication date
EP0668769A1 (en) 1995-08-30
JP3640215B2 (ja) 2005-04-20
DK0668769T3 (da) 2000-10-02
ATE191850T1 (de) 2000-05-15
BR9307401A (pt) 1999-08-24
DE69328438D1 (de) 2000-05-25
HUT73791A (en) 1996-09-30
EP0668769B1 (en) 2000-04-19
HU9501323D0 (en) 1996-05-28
ZA938274B (en) 1994-06-09
AU5550094A (en) 1994-06-08
PT668769E (pt) 2000-10-31
WO1994011010A3 (en) 1994-09-15
US6149947A (en) 2000-11-21
CA2148795C (en) 2004-08-10
AU700019B2 (en) 1998-12-17
CA2148795A1 (en) 1994-05-26
NO951740D0 (no) 1995-05-04
OA10153A (en) 1996-12-18
NZ258019A (en) 1998-12-23
DE69328438T2 (de) 2001-01-04
MX9306960A (es) 1995-01-31
CZ117395A3 (en) 1995-11-15
ES2147780T3 (es) 2000-10-01
JPH08503462A (ja) 1996-04-16
CY2231B1 (en) 2003-04-18
PL308770A1 (en) 1995-08-21
WO1994011010A2 (en) 1994-05-26

Similar Documents

Publication Publication Date Title
NO951740D0 (no) Preparater av eikebarkekstrakt, beslektede syntetiske preparater og fremgangsmåte for anvendelse av disse
GR3006001T3 (no)
WO1994011010B1 (en) Compositions of oak bark extract, related synthetic compositions, and method of using same
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
MX9200675A (es) Derivados de 2,4-diaminoquinazolinas para mejorar la actividad antitumoral.
DE69132048D1 (de) Verwendung von Steroiden zur Inhibierung von Angiogenesis
AU6256996A (en) Use of vitamin D4 derivatives for treating skin disorders
RU94042393A (ru) Галихондрины, родственные соединения и способ лечения опухоли у млекопитающих
ATE225340T1 (de) Einschlusskomplexe von taxol oder taxotere oder taxus-extrakten und cyclodextrinen, ihre herstellung und ihre verwendung
DE69230798D1 (de) Rekombinante immuntoxine
EP0325129A3 (en) Disubstituted pyridines
DE59002154D1 (de) Kombinationspraeparate enthaltend rifampicin und thioacetazon sowie gegebenenfalls isonicotinsaeurehydrazid oder ethambutol als aktive wirkstoffe.
ATE78164T1 (de) Verwendung von metalloporphyrin zur umkehr des toxischen effekts der tumortherapie.
DE69232852D1 (de) Verwendung von topotecan in der behandlung von nichtkleinzelligen lungenkarzinomen
NZ220495A (en) A2a cyclopeptan-2-ones carrier containing methotrexate compositions
ATE87314T1 (de) Platin-arzneimittel.
DE3485282D1 (de) Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren.
ATE214923T1 (de) Verwendung von (r)-verapamil als medizin zur behandlung von angina
GB8428552D0 (en) Organic compounds
ES2112562T3 (es) Nuevo difenilhexeno.
UA8280A (uk) Спосіб лікування псоріазу